BioVersys AG banner
B

BioVersys AG
SIX:BIOV

Watchlist Manager
BioVersys AG
SIX:BIOV
Watchlist
Price: 24.8 CHF -1.59% Market Closed
Market Cap: CHf145.1m

Wall St Price Targets

BIOV Price Targets Summary
BioVersys AG

Wall Street analysts forecast BIOV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOV is 58.48 CHF with a low forecast of 40.4 CHF and a high forecast of 73.5 CHF.

Lowest Forecast
Price Target
40.4 CHF
63% Upside
Average Forecast
Price Target
58.48 CHF
136% Upside
Highest Forecast
Price Target
73.5 CHF
196% Upside
BioVersys AG Competitors:
Price Targets
SPT6
Sparta AG
36% Upside
PACB
Pacific Biosciences of California Inc
94% Upside
PEN
Pennant International Group PLC
41% Upside
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BIOV's stock price target?
Price Target
58.48 CHF

According to Wall Street analysts, the average 1-year price target for BIOV is 58.48 CHF with a low forecast of 40.4 CHF and a high forecast of 73.5 CHF.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett